Showing results (461-470 of 493) with videos related to
Sort By:
Pageof 50
Bioorganic & Medicinal Chemistry Letters|June 11, 2005
Substituted tetraazaacenaphthylenes as potent CRF1 receptor antagonists for the treatment of depression and anxietyY St-Denis, R Di Fabio, G Bernasconi, et al.Elife|June 23, 2020
A divergent cyclin/cyclin-dependent kinase complex controls the atypical replication of a malaria parasite during gametogony and transmissionAurélia C Balestra, Mohammad Zeeshan, Edward Rea, et al.ACS Nano|September 17, 2016
High-Resolution Analysis of Antibodies to Post-Translational Modifications Using Peptide Nanosensor MicroarraysJung-Rok Lee, D James Haddon, Nidhi Gupta, et al.Diseases of the Colon and Rectum|June 15, 2026
Patient-Level Socioecological Comorbidities and Time to Initiation of Curative-Intent Treatment for Colorectal CancerYuqing Huang, Kurt S Schultz, Madeline L D'Aquila, et al.JMIR Cancer|November 2, 2023
Telehealth Availability for Cancer Care During the COVID-19 Pandemic: Cross-Sectional StudyVictoria A Marks, Walter R Hsiang, James Nie, et al.Annals of Vascular Surgery|September 1, 2020
Prevalence and Outcomes of Endovascular Infrapopliteal Interventions for Intermittent ClaudicationC Haddon Mullins, Zdenek Novak, John C Axley, et al.Journal of Proteomics|May 19, 2015
Multicenter experiment for quality control of peptide-centric LC-MS/MS analysis - A longitudinal performance assessment with nLC coupled to orbitrap MS analyzersAlex Campos, Ramón Díaz, Salvador Martínez-Bartolomé, et al.Autoimmunity|September 4, 2015
Mapping epitopes of U1-70K autoantibodies at single-amino acid resolutionDavid James Haddon, Justin Ansel Jarrell, Vivian K Diep, et al.Journal of Gastroenterology and Hepatology|April 22, 2023
Idiopathic myointimal hyperplasia of the mesenteric veins: A systematic review and individual patient data regression analysisRaquel Rozner, Savanah Gisriel, John Damianos, et al.Nature Medicine|November 9, 2021
Fenebrutinib in H1 antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trialMartin Metz, Gordon Sussman, Rémi Gagnon, et al.Pageof 50